⌕
Innoviva · INVA · Nasdaq
Tenet 73 · Solid
Compare
$18.49−2.84%At closeTenet 73 · Solid
$18.49−0.54 (−2.84%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Innoviva (INVA) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice

2 figures withheld by our checks. Each blank figure names its reason.

Business engineChoppy: revenue compounds ~1.2%/yr (FY21→FY25), net margin 65.9%; free cash flow runs at 72% of net income. Check the accrual gap. Worth your attention in FY25: Capex step-up ($1.1M). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲14.7%
411.3
FY21→FY25CAGR +1.2%/yr
Net income ($M)▲1059.2%
271.2
one-off year: see footnoteCAGR −7.4%/yr
Free cash flow ($M)▲3.9%
195.8
capex stepped upCAGR −14.3%/yr
Diluted EPS▲816.7%
3.30
buyback-liftedCAGR +3.6%/yr
What the receipts whisper · what a headline number hides
Share count
−10.1%

94.3mn → 84.8mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex step-up
$1.1M

▲319% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)411.3Revenue−103.7COGS307.7Gross profit−30.6R&D−113.3SG&A163.7Op income107.4Tax & other271.2Net income

66¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
1209060300%sector median net margin ~4%FY21FY25

Over this window: gross 100.0% → 74.8%. Net margin 65.9% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
438,318.0411,328.0358,711.0310,463.0331,339.0391,866.0▲14.7%+1.2%
Cost of revenue
111,820.0103,661.062,500.064,424.013,793.00.0▲65.9%+95.9% (22→25)
Gross profit
326,498.0307,667.0296,211.0246,039.0—A391,866.0▲3.9%—
Research & development
20,200.030,604.013,654.033,922.041,432.0576.0▲124.1%+170.0%
Selling, general & admin
136,148.0113,318.0115,690.098,232.063,538.016,187.0▼2.1%+62.7%
Total operating expenses
156,348.0143,922.0129,344.0132,154.0−2,858.0−74,267.0▲11.3%—
Operating incomefeeds ROC rank
170,150.0163,745.0166,867.0113,885.0320,404.0466,133.0▼1.9%−23.0%
Other income, net
53,819.0163,117.0−129,479.080,213.0−33,455.0−20,857.0——
Pretax income
223,969.0326,862.037,388.0194,098.0286,949.0445,276.0▲774.2%−7.4%
Income tax
30,529.055,697.013,996.014,376.066,687.076,439.0▲297.9%−7.6%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
193,440.0271,165.023,392.0179,722.0220,262.0368,837.0▲1059.2%−7.4%
Per share
Diluted EPSbuyback-sensitive
2.243.300.362.202.372.87▲816.7%+3.6%
Diluted shares (mn)
72.0784.7674.1986.8895.2594.31▲14.3%−2.6%
Margins
Gross margin67th pct in Healthcare
74.5%74.8%82.6%79.2%—A100.0%▼7.8pp—
Operating margin
38.8%39.8%46.5%36.7%96.7%119.0%▼6.7pp−79.1pp
Net margin98th pct in Healthcare
44.1%65.9%6.5%57.9%66.5%94.1%▲59.4pp−28.2pp
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 7% vs a 17% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was 37% vs a 17% norm for this window, likely a one-time item; see the filing.A Withheld: this year's gross margin is not on the same cost basis as the earlier years.
FY09 – FY20 · 12 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-25 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Innoviva's revenue last fiscal year?

Innoviva reported revenue of $411.3M in fiscal 2025, up 14.7% from fiscal 2024.

What was Innoviva's net income?

Innoviva reported net income of $271.2M in fiscal 2025, a net margin of 65.9%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.